Aurobindo Pharma Limited Aurobindo Pharma Limited

Aurobindo Pharma Limited

AUROPHARMA

株式のランク #2018
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
株価
$17.89
最終同期: 2026-10-19
時価総額
$10.30B
変化(1日)
-2.27%
変化(1年)
43.03%
国
IN
取引 Aurobindo Pharma Limited (AUROPHARMA)

カテゴリー

Healthcare
Aurobindo Pharma Limited(AUROPHARMA)のEPS
June 2026 時点のEPS TTM: $0.71
Aurobindo Pharma Limitedの最新の財務報告と株価によると、同社の現在のEPS(TTM)は$0.71です。2024年末には、EPSは$0.65で、2023年のEPS$0.40と増加でした。
Aurobindo Pharma LimitedのEPS履歴(2004から2026まで)
各年末時点のEPS
年 EPS 変化
2026 (TTM) $0.71 0.90%
2025 $0.70 7.68%
2024 $0.65 62.23%
2023 $0.40 -32.77%
2022 $0.60 -52.13%
2021 $1.24 92.96%
2020 $0.64 10.91%
2019 $0.58 -8.50%
2018 $0.64 4.73%
2017 $0.61 15.90%
2016 $0.52 20.94%
2015 $0.43 -3.95%
2014 $0.45 384.93%
2013 $0.09 -322.25%
2012 $-0.04 -119.03%
2011 $0.22 -5.22%
2010 $0.23 529.89%
2009 $0.04 -66.91%
2008 $0.11 27.82%
2007 $0.09 190.97%
2006 $0.03 1,893.33%
2005 0.00 -97.13%
2004 $0.05 0.00%